One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: Results of a multicenter registry

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 3, 2007, Pages 372-377

  Sanmartin, Marcelo ^a   Baz, Jose Antonio ^a   Lozano, Iñigo ^b   De La Torre, Jose Maria ^c   Hernandez, Jose Maria ^d   Bordes, Pascual ^e   Mainar, Vicente ^e   Mauri, Josepa ^f   Iñiguez, Andrés ^a  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d Hospital Clinico de Malaga   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Angioplasty; Left main; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; FATALITY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETREATMENT; ST SEGMENT ELEVATION; UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; REOPERATION; RESEARCH DESIGN; SPAIN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33847381912     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20960     Document Type: Article

References (11)

1. Suarez-de-Lezo J, Medina A, Pan M, Delgado A, Segura J, Pavlovic D, Melian F, Romero M, Burgos L. Hernandez E, Ureña I, Herrador J. Rapamycin-eluting stems for the treatment of unprotected left main coronary disease. Am Heart J 2004;148:481-485.
2. Park SJ, Kim YH, Lee BK, Lee SW, Whan C, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis. Comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-356.
3. Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CA, Ligthart JM, Ong AT, Sianos G, Regar E, Van Domburg RT, De Feyter P, de Jaegere P, Serruys PW. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: A combined RESEARCH and T-SEARCH long-term analysis. Circulation 2005;111:1383-1389.
4. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005;111:791-795.
5. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de Jaegere P, De Feyter P, Serruys PW. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: An integrated clinical and angiographic analysis based on the -Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 2006;47:1530-1537.
6. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa RA, Lansky AJ, Teirstein PS. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 2006;47:871-877.
7. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870.
8. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G, Sangiorgi G. Alfieri O, Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience. Circulation 2006;113:2542-2547.
9. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, Bacchi-Reggiani L, Gianstefani S, Virzš S, Manara F, Weldeab MK, Marinelli G, Di Bartolomeo R, Branzi A. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006;98:54-59.
10. Hong MK, Park SW, Lee CW, Kang DH, Song JK, Kim JJ, Park SJ, Hong MK, Mintz GS, Leon MB. Intravascular ultrasound findings in stenting of unprotected left main coronary artery stenosis. Am J Cardiol 1998;82:670-673.
11. Costa MA, Gigliotti OS, Zenni MM, Gilmore PS, Bass TA. Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease. Catheter Cardiovasc Interv 2004;61:368-375.